European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 496-500 , May 2010

Postresection survival outcomes of pancreatic cancer according to demographic factors and socio-economic status

,Accepted 17 August 2009.

References 

  1. Alboni P, Amadei A, Scarfo S, Bettiol K, Ippolito F, Baggioni G. In industrialized nations, a low socioeconomic status represents an independent predictor of mortality in patients with acute myocardial infarction. Ital Heart J. 2003;4(8):551–558
  2. Queen S, Pappas G, Hadden W, Fisher G. The widening gap between socioeconomic status and mortality. Stat Bull Metrop Insur Co. 1994;75(2):31–35
  3. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–109
  4. Marmot MG, McDowall ME. Mortality decline and widening social inequalities. Lancet. 1986;2(8501):274–276
  5. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237(1):74–85
  6. Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. 2006;17(4):403–409
  7. Zell JA, Rhee JM, Ziogas A, Lipkin SM, nton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16(3):546–552
  8. Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the national cancer database. Cancer. 2007;110(4):738–744
  9. Boyd C, Zhang-Salomons JY, Groome PA, Mackillop WJ. Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol. 1999;17(7):2244–2255
  10. Coleman MP, Rachet B, Woods LM, et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer. 2004;90(7):1367–1373
  11. Hui AC, Vinod SK, Jalaludin BB, Yuile P, Delaney GP, Barton MB. Socio-economic status and patterns of care in lung cancer. Aust N Z J Public Health. 2005;29(4):372–377
  12. Menvielle G, Leclerc A, Chastang JF, Luce D. Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996. Br J Cancer. 2006;94(1):152–155
  13. Shaw C, Blakely T, Sarfati D, Fawcett J, Peace J. Trends in colorectal cancer mortality by ethnicity and socio-economic position in New Zealand, 1981–99: one country, many stories. Aust N Z J Public Health. 2006;30(1):64–70
  14. Ueda K, Kawachi I, Tsukuma H. Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Sci. 2006;97(4):283–291
  15. Batty GD, Der G, Macintyre S, Deary IJ. Does IQ explain socioeconomic inequalities in health? Evidence from a population based cohort study in the West of Scotland. BMJ. 2006;332(7541):580–584
  16. Donelan K, Blendon RJ, Benson J, Leitman R, Taylor H. All payer, single payer, managed care, no payer: patients' perspectives in three nations. Health Aff (Millwood). 1996;15(2):254–265
  17. Schrijvers CT, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP. Deprivation, stage at diagnosis and cancer survival. Int J Cancer. 1995;63(3):324–329
  18. Du XL, Fang S, Coker AL, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006;106(6):1276–1285
  19. Southern DA, Faris PD, Knudtson ML, Ghali WA. Prognostic relevance of census-derived individual respondent incomes versus household incomes. Can J Public Health. 2006;97(2):114–117
  20. Isaacs SL, Schroeder SA. Class – the ignored determinant of the nation's health. N Engl J Med. 2004;351(11):1137–1142
  21. Goldberg J, Hayes W, Huntley J. Understanding health disparities. Health Policy Institute of Ohio; 2004;
  22. van Heek NT, Kuhlmann KF, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg. 2005;242(6):781–788
  23. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007;245(5):777–783
  24. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001;358(9293):1576–1585
  25. Neoptolemos JP, Raraty MG, Ghaneh P, et al. Adjuvant and additive therapy for cancer of the pancreas, Chirurg. 2003;74(3):191–201
  26. Standop J, Glowka T, Schmitz V, et al. Operative re-intervention following pancreatic head resection: indications and outcome. J Gastrointest Surg. 2009;13:1503–1509
  27. DiPietro A. Universal problems & universal healthcare: 6 countries – 6 systems. Oregon's Future. Fall 2004;27–32:
  28. World Health Organisation (WHO) . World health report 2008 – primary health care. Geneva: World Health Organisation (WHO); 2008;

PII: S0748-7983(09)00438-7

doi: 10.1016/j.ejso.2009.08.006

European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 496-500 , May 2010

Article Tools

* Image Usage & Resolution